Advisor Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $5.76M | Buy |
23,677
+1,646
| +7% | +$403K | 0.41% | 45 |
|
|
2022
Q1 | $5.33M | Buy |
22,031
+1,343
| +6% | +$309K | 0.33% | 53 |
|
|
2021
Q4 | $4.66M | Sell |
20,688
-1,144
| -5% | -$241K | 0.28% | 61 |
|
|
2021
Q3 | $4.64M | Sell |
21,832
-2,798
| -11% | -$644K | 0.31% | 59 |
|
|
2021
Q2 | $6M | Sell |
24,630
-333
| -1% | -$81.9K | 0.39% | 49 |
|
|
2021
Q1 | $6.21M | Sell |
24,963
-1,951
| -7% | -$466K | 0.44% | 46 |
|
|
2020
Q4 | $6.19M | Sell |
26,914
-1,303
| -5% | -$300K | 0.47% | 44 |
|
|
2020
Q3 | $7.17M | Buy |
28,217
+114
| +0.4% | +$28.2K | 0.62% | 34 |
|
|
2020
Q2 | $6.63M | Buy |
28,103
+548
| +2% | +$125K | 0.62% | 35 |
|
|
2020
Q1 | $5.59M | Buy |
27,555
+7,060
| +34% | +$1.54M | 0.68% | 32 |
|
|
2019
Q4 | $4.95M | Buy |
20,495
+1,361
| +7% | +$300K | 0.51% | 44 |
|
|
2019
Q3 | $3.7M | Buy |
19,134
+2,024
| +12% | +$389K | 0.45% | 44 |
|
|
2019
Q2 | $3.15M | Sell |
17,110
-2,874
| -14% | -$515K | 0.38% | 48 |
|
|
2019
Q1 | $3.8M | Buy |
19,984
+1,468
| +8% | +$280K | 0.49% | 41 |
|
|
2018
Q4 | $3.6M | Buy |
18,516
+1,389
| +8% | +$271K | 0.58% | 35 |
|
|
2018
Q3 | $3.55M | Buy |
17,127
+568
| +3% | +$112K | 0.48% | 42 |
|
|
2018
Q2 | $3.06M | Buy |
16,559
+593
| +4% | +$105K | 0.52% | 42 |
|
|
2018
Q1 | $2.72M | Buy |
15,966
+1,301
| +9% | +$239K | 0.5% | 44 |
|
|
2017
Q4 | $2.78M | Buy |
14,665
+1,172
| +9% | +$207K | 0.5% | 42 |
|
|
2017
Q3 | $2.52M | Buy |
13,493
+884
| +7% | +$157K | 0.49% | 41 |
|
|
2017
Q2 | $2.17M | Buy |
12,609
+233
| +2% | +$37.9K | 0.51% | 40 |
|
|
2017
Q1 | $2.03M | Buy |
12,376
+1,646
| +15% | +$274K | 0.54% | 38 |
|
|
2016
Q4 | $1.57M | Sell |
10,730
-770
| -7% | -$116K | 0.47% | 48 |
|
|
2016
Q3 | $1.92M | Buy |
11,500
+421
| +4% | +$71.2K | 0.64% | 36 |
|
|
2016
Q2 | $1.69M | Buy |
11,079
+270
| +2% | +$42K | 0.59% | 40 |
|
|
2016
Q1 | $1.62M | Sell |
10,809
-1,477
| -12% | -$219K | 0.6% | 40 |
|
|
2015
Q4 | $2M | Buy |
12,286
+2,241
| +22% | +$352K | 0.68% | 36 |
|
|
2015
Q3 | $1.39M | Sell |
10,045
-1,531
| -13% | -$241K | 0.58% | 39 |
|
|
2015
Q2 | $1.83M | Buy |
11,576
+1,913
| +20% | +$306K | 0.7% | 35 |
|
|
2015
Q1 | $1.54M | Sell |
9,663
-212
| -2% | -$33.4K | 0.66% | 38 |
|
|
2014
Q4 | $1.57M | Buy |
9,875
+739
| +8% | +$115K | 0.7% | 35 |
|
|
2014
Q3 | $1.28M | Buy |
9,136
+12
| +0.1% | +$1.57K | 0.73% | 34 |
|
|
2014
Q2 | $1.08M | Buy |
9,124
+937
| +11% | +$108K | 0.53% | 49 |
|
|
2014
Q1 | $1.01M | Buy |
8,187
+175
| +2% | +$21.2K | 0.55% | 47 |
|
|
2013
Q4 | $914K | Buy |
8,012
+131
| +2% | +$14.9K | 0.53% | 52 |
|
|
2013
Q3 | $882K | Buy |
7,881
+703
| +10% | +$76.2K | 0.63% | 44 |
|
|
2013
Q2 | $708K | Buy |
+7,178
| New | +$745K | 0.58% | 45 |
|
Other funds holding AMGN
Advisor Partners's AMGN Position: Q2 2022 in Review
Advisor Partners increased its Amgen (AMGN) stake by 7.5% in Q2 2022, buying an estimated $403K and bringing the position to 23,677 shares worth $5.76M. The position accounts for 0.41% of the portfolio, ranked #45.
Advisor Partners first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $7.17M in Q3 2020. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.
- Advisor Partners held 23,677 shares of Amgen worth $5.76M as of Q2 2022.
- Advisor Partners bought 1,646 Amgen shares in Q2 2022, an estimated $403K.
- Amgen made up 0.41% of Advisor Partners's portfolio in Q2 2022, its #45 holding.
- Advisor Partners first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
- Advisor Partners's Amgen position peaked at $7.17M in Q3 2020.
- 2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.